Volume 16, Issue 3 (May & June 2025)
BCN 2025, 16(3): 667-676 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Moarrefzadeh A, Sarandili S, Motamed-Gorji N, Majdolashrafi F, Bahardoust M, Mousavi S, et al . Predictors of Quality of Life in Patients With Parkinson’s Disease: A Multicenter Case-control Study. BCN 2025; 16 (3) :667-676
URL: http://bcn.iums.ac.ir/article-1-2987-en.html
URL: http://bcn.iums.ac.ir/article-1-2987-en.html
Predictors of Quality of Life in Patients With Parkinson’s Disease: A Multicenter Case-control Study
Aida Moarrefzadeh1 
, Sadra Sarandili2 , Nogol Motamed-Gorji3 , Fatemeh Majdolashrafi4 , Mansour Bahardoust4 , Safa Mousavi5 , Neda Hashemi6 , Arash Sarveazad7 , Mohammadhossein Vazirizadeh-Mahabadi8 , Seyed Amirhassan Habibi *9
, Sadra Sarandili2 , Nogol Motamed-Gorji3 , Fatemeh Majdolashrafi4 , Mansour Bahardoust4 , Safa Mousavi5 , Neda Hashemi6 , Arash Sarveazad7 , Mohammadhossein Vazirizadeh-Mahabadi8 , Seyed Amirhassan Habibi *9
1- Department of Psychology, Faculty of Humanities, Ahar Branch, Islamic Azad University, Ahar, Iran.
2- Department of Health Sciences, Curtin Medical School, Curtin University, Perth, Australia.
3- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
4- Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5- Department of Public Health, College of Health and Human Services, California State University, Fresno, United States.
6- Department of Perinatology, Endometriosis Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
7- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran. & Nursing Care Research Center, Iran University of Medical Sciences, Tehran, Iran.
8- Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
9- Department of Movement Disorders, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
2- Department of Health Sciences, Curtin Medical School, Curtin University, Perth, Australia.
3- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
4- Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5- Department of Public Health, College of Health and Human Services, California State University, Fresno, United States.
6- Department of Perinatology, Endometriosis Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
7- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran. & Nursing Care Research Center, Iran University of Medical Sciences, Tehran, Iran.
8- Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
9- Department of Movement Disorders, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abstract:
Introduction: Parkinson’s disease (PD) is a common neurodegenerative disease whose motor and non-motor complications significantly affect a person’s quality of life (QoL). This study aimed to investigate the QoL of these patients using the PD questionnaire (PDQ)-39 and identify the prognostic factors associated with their QoL.
Methods: In this case-control study, the QoL of two groups (211 controls and 211 cases) was investigated and compared using the PDQ-39 questionnaire. Prognostic factors associated with QoL were determined using multivariate logistic regression analyses.
Results: Several 422 patients with a mean age of 59.8±13.7 years were included in the study. The mean PDQ-39 score in the case group was significantly higher in all subscales, except for social support, compared to the control group. The mean score of PDQ-39 was significantly higher in the patients with non-deep brain stimulation (DBS) (53.9±21.1 (than those with DBS (42.22±18.1), especially in the sub-scales of mobility, activities of daily living, cognition, and communication. As the stage of the disease increased, the mean PDQ-39 score in these patients increased significantly. The results of the multivariate analysis showed that sex, patient age, smoking, education level, duration of disease, patient stage, and intervention with DBS were significantly related to patients’ QoL (P<0.05).
Conclusion: This study highlights the significant impact of DBS on PD patients’ QoL, especially in sub-scales of mobility, daily activities, emotional well-being, and cognition. Moreover, identifying the main prognostic factors of QoL (sex, age, smoking status, educational level, disease duration, and stage) can lead to avenues for improving the lives of these patients.
Methods: In this case-control study, the QoL of two groups (211 controls and 211 cases) was investigated and compared using the PDQ-39 questionnaire. Prognostic factors associated with QoL were determined using multivariate logistic regression analyses.
Results: Several 422 patients with a mean age of 59.8±13.7 years were included in the study. The mean PDQ-39 score in the case group was significantly higher in all subscales, except for social support, compared to the control group. The mean score of PDQ-39 was significantly higher in the patients with non-deep brain stimulation (DBS) (53.9±21.1 (than those with DBS (42.22±18.1), especially in the sub-scales of mobility, activities of daily living, cognition, and communication. As the stage of the disease increased, the mean PDQ-39 score in these patients increased significantly. The results of the multivariate analysis showed that sex, patient age, smoking, education level, duration of disease, patient stage, and intervention with DBS were significantly related to patients’ QoL (P<0.05).
Conclusion: This study highlights the significant impact of DBS on PD patients’ QoL, especially in sub-scales of mobility, daily activities, emotional well-being, and cognition. Moreover, identifying the main prognostic factors of QoL (sex, age, smoking status, educational level, disease duration, and stage) can lead to avenues for improving the lives of these patients.
Keywords: Parkinson, Quality of life (QoL), Parkinson’s disease questionnaire (PDQ)-39, Prognostic factors
Type of Study: Original |
Subject:
Cellular and molecular Neuroscience
Received: 2024/07/28 | Accepted: 2024/08/18 | Published: 2025/05/1
Received: 2024/07/28 | Accepted: 2024/08/18 | Published: 2025/05/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
